← SynDRA
ELCUBRAGISTAT
SynDRA canonical compound SYN0038659 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MGLL |
|---|
| Mechanism of action | monoacylglycerol lipase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MGLL INHIBITOR
- Monoglyceride lipase inhibitor
- ABHD6 INHIBITOR
- MGLL IRREVERSIBLE INHIBITION
- PLA2G7 INHIBITOR
- monoacylglycerol lipase inhibitor
Cross-references
Synonyms
- ABX-1431
- ABX1431
- SQZJGTOZFRNWCX-UHFFFAOYSA-N
- CHEMBL3945728
- SCHEMBL15100632
- BDBM180052
- US9133148, 9aq
- ABX 1431
- FB39E94UXK
- RefChem:108585
- MGLL Inhibitor ABX-1431
- Serine Hydrolase Monoacylglycerol Lipase Inhibitor ABX-1431
- UNII-FB39E94UXK
- ELCUBRAGISTAT [INN]
- orb1301861
- GTPL10062
- C20H22F9N3O2
- GLXC-20011
- EX-A2760
- ABX-1431?
- EBC-07964
- MFCD31735112
- s8823
- AKOS037515667
- compound 28 [PMID: 30067909]
- compound 9aq [WO2013103973A1]
- AC-35611
- BA167497
- BS-15747
- DA-70463
- example 82 [WO2013103973A1]
- SY380946
- HY-117632
- CS-0066666
- T5353
- D80627
- Z3692177058
- ABX-1431 hydrochloride?
Look up ELCUBRAGISTAT in the interactive SynDRA portal →